JOIN OUR APAC 2018 STRATEGY MEETING
8th May 2018 | Swissotel Merchant Court, Singapore
OUR UNIQUE FORMAT
Providing a different approach to business networking, Proventa International's unique format offers a more interactive and meaningful dialogue among business leaders in an informal setting. Unlike clinical trial and supply chain conferences, attendees are pre-qualified so you only meet primary decision makers of large and emerging pharma and biotech organizations. Personalized and intimate, our executive roundtable discussions let you dive deep into clinical trial and supply chain trends that matter to you like the latest technology, best practices in packaging, storage and more. Each individual gets the chance to raise relevant questions and contribute insights to the discussions, something you would find almost impossible to do at a supply chain summit.
Another major difference of our strategy meeting from clinical trial conferences is our one-to-one meetings. Meet with clinical trial and supply chain experts from Asia and around the world to discover backed-by-data studies you can leverage to help you achieve short to long-term goals. Trying to create strategies on more cost-efficient clinical trials? Just let us know and we'll schedule you with someone who can help!
Business leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
Clinical Trials Supply Chain
Product Research and Development
Clinical Drug Supply
Clinical Supply Strategic Resource
Biologics Supply Chain
Clinical Supplies Quality
Brand Safety & Security
Regional Clinical Trial Management
Technical Operations and Manufacturing
Global Clinical Supply
Investigational Material Supply Chain
Clinical Supply Logistics
The Clinical Trial Supply Chain Strategy Meeting is happening on May 8, 2018 at Swissotel Merchant Court in Singapore. Download the full agenda here.
To see other strategy meetings happening near you, click here.
Dr Yee Leong TeohChief Executive Officer
Singapore Clinical Research Institute
Dr Sakthivel Sekar PhD MBAChief Executive Officer
Allen LaiSenior Vice President
Vincenzo TeneggiSenior Medical Director
D3 A*Star, Singapore
Pei Yin TanDirector, Asia Clinical Operations
Eisai Clinical Research Singapore Pte Ltd
Joshua ChooSupply Chain Director
Dr Josemund MenezesDirector- Medical Affairs & Clinical Development
Christian CaterHead of Operational Excellence
WHAT TO EXPECT
Interactive Roundtable Discussions
Attendees can proactively share and ask questions to their peers about the success of their work in an informal setting.
Director level one-to-one meetings
We provide opportunities to engage with one another in our strategy meeting in a series of pre-arranged business meetings by interacting face to face.
Tailor-fit and Personalized Agenda
Being able to experience different sessions is what makes our event unique that’s why our attendees can personalize and select sessions they want to participate in.
Several networking opportunities are in store for attendees to connect and build new relationships with their peers through luncheons, cocktails and informal introductions.
Thank you for reaching Proventa International
CLINICAL TRIAL SUPPLY CHAIN
***The information you provided in this website is confidential and the company will strictly forbidden to share any part of these information with any third party without a written consent of the sender.
Our unique strategy meeting platform ensures that delegates can network with peers and benchmark their challenges whilst meeting a select number of supplier organizations that are currently at the forefront of innovation. This in turns helps them to save time and money associated in sourcing the best suppliers to procure solutions in an environment, which is 100% conducive to doing business.
If you are an exciting start-up trying to get your innovation in front global heads from the leading Pharmaceutical companies,
or a mature market-leading conglomerate with legacy solutions trying to stay one step ahead of the competition – we are here to help!
WHAT PEOPLE SAY
Clinical Trial Supply Chain Strategy Meeting US East Coast 2016,
Pharma Supply Chain EU 2016 , Return on Investment attained at the meeting and why they are coming back
Chief Information Officer
Its nice because they basically allowed people to engaged to discussions and questions. Academic and industry is very nice and informative
Ivan John Clement
Data Scientist - R&D
Its good because you really get the people to talk. They are willing to share their knowledge, the juniors are very eager to learn.
Manager Quality Assurance
The format is the beginning of breakthrough and integration, the level of delegates is very good and excellent, they learn a lot.
Founder & President
The kind of interaction is very interactive
Director & Professor
Because of diversity we really districts the points and all. People are very diversity and thoughtful in a round table.
Images coming soon
SWISSOTEL MERCHANT COURT
20 Merchant Rd, Singapore 058281
+65 6337 2288
OUR MEDIA PARTNERS
Dr. Yee Leong Teoh
Chief Executive Officer, Singapore Clinical Research Institute
Dr. Sakthivel Sekar PhD MBA
Chief Executive Officer, Sinopsee Therapeutics
Senior Vice President, ACT Genomics
Senior Medical Director, D3 A*Star, Singapore
Supply Chain Director, Amgen
Dr. Josemund Menezes
Director- Medical Affairs & Clinical Development, Tessa Therapautics
Head of Operational Excellence, Roche
Pei Yin Tan
Director, Asia Clinical Operations, Eisai Clinical Research Singapore Pte Ltd
With a career spanning more than 10 years in clinical research and across academia to pharmaceutical and biotech companies, Pei Yin is the Head of Eisai Clinical Research Singapore, one of the regional clinical offices of Eisai, a global pharmaceutical company. Since joining the company, she has served in positions of increasing responsibility and is now leading a team responsible for neurology and oncology clinical trials in Asia Pacific.
Pei Yin is a registered pharmacist, with an honours degree from the National University of Singapore. She sees the untapped potential in this region for global clinical needs and firmly believes in continuing to develop talents in this field.